Analysed ASCLETIS PHARMA INC (ASCLF:OTCMKTS) News Sources
A Look At Ascletis Pharma SEHK:1672 Valuation After ASC30_39 Obesity Candidate Advances Toward US FDA IND
09-04-2026
yahoo.com
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
07-04-2026
yahoo.com
Analysts Remain Optimistic in Sagimet Biosciences (SGMT)’s Outlook Following Q4 and Full-Year 2025 Results
25-03-2026
yahoo.com
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
11-03-2026
yahoo.com
Ascletis Announces Positive Topline Results from U.S. Phase II, 24-Week Study for Its Ultra-Long-Acting Subcutaneous Depot Formulations of Small Molecule GLP-1R Agonist ASC30 for Obesity
10-03-2026
yahoo.com
Sagimet Biosciences Highlights Denifanstat MASH Data, Combo Plans at Oppenheimer Healthcare Conf.
01-03-2026
marketbeat.com
Sagimet Biosciences Showcases FASN Strategy, MASH Phase II Timeline and Acne Data at Guggenheim Conference
15-02-2026
marketbeat.com
Ascletis Selects Oral Amylin Receptor Peptide Agonist, ASC36, for Clinical Development
10-02-2026
yahoo.com
What is the current price of ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?
The current price of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is $2.1.
ASCLETIS PHARMA INC (ASCLF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) since the previous trading day is $0.29.
ASCLETIS PHARMA INC (ASCLF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) since the previous trading day is 16.0221%.
What is the most recent average sentiment score for ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?
The most recent average sentiment score for ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is 76 out of 100.
What is the most recent average sentiment for ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?
The most recent sentiment for ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is .
SEC-8K** Filing Available For ASCLETIS PHARMA INC (ASCLF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.